NP
Neurofix Pharma S.A.
The startup develops lipid-based therapies targeting neuropathic pain in spinal cord injury patients and other neurological disorders. Its biotechnology platform simplifies treatment options for individuals suffering from various neurological conditions.
- Biotechnology
Updated 6 months ago
Funding
Raised to date
$3.5MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops lipid-based therapies targeting neuropathic pain in spinal cord injury patients and other neurological disorders. Its biotechnology platform simplifies treatment options for individuals suffering from various neurological conditions.